Fundraising Fox
Flow Pharma
Warrensville Heights, US · Delaware corporation · 1 known investors
Find your way into Flow Pharma
Sign up to see every warm intro you have to Flow Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Flow Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RM
RM
TB
Thomas BradyBusiness Development Executive2015–2024Thomas Brady served as VP of Business Development at Flow Pharma for nine years, focusing on capital raising and international partnerships for cancer therapies and research. He holds degrees from UC Berkeley and Stanford GSB, and serves as a Venture Partner with the Global Health Impact Fund.
LJ
Lester John LloydExecutive
Board
PS
Pamela SteeleBoard director
AT
Anthony TufaroBoard director
TB
Tikoes BlankenbergBoard director
BO
Babatunde OtulanaBoard director
Investors · 1
Also in the syndicate · 1
Button Capital
Funding
SEC filings, press & company announcements$3.8M disclosed across 4 of 5 rounds · 2011–2024
- Undisclosed amountSeed RoundSep 2018
Button Capital
Source ↗
▶$225KraisedAug 2024 · 3 investors · BiotechnologyRule 506(b)
▶$225KraisedAug 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Pamela SteeleDirector
- Anthony TufaroDirector
- Reid Martin RubsamenExecutive Officer, Director
- Tikoes BlankenbergDirector
- Babatunde OtulanaDirector
- Offering amount
- $40M
- Amount sold
- $225K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$180KraisedNov 2022 · 8 investors · BiotechnologyRule 506(c)
▶$180KraisedNov 2022 · 8 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Gil Van BokkelenExecutive Officer
- Reid Martin RubsamenExecutive Officer, Director
- Tikoes BlankenbergDirector
- Thomas BarnishExecutive Officer
- Stephen FarrDirector
- Charles Vincent HerstExecutive Officer
- Tom BradyExecutive Officer
- Pamela SteeleDirector
- Babatunde OtulanaDirector
- Offering amount
- $10.5M
- Amount sold
- $180K
- Finders' fees
- $500K
- Placement agents
- Carleton McKenna Advisors, LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$2.3MraisedFeb 2018 · 42 investors · BiotechnologyRule 506(b)
▶$2.3MraisedFeb 2018 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Reid Michael RubsamenExecutive Officer, Director
- Thomas BradyExecutive Officer
- Lester John LloydExecutive Officer, Director
- Amount sold
- $2.3M
- Minimum investment
- $5K
- Proceeds to insiders
- $300K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2018 · 17 investors · BiotechnologyRule 506(b)
▶$1.1MraisedFeb 2018 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Reid M RubsamenExecutive Officer, Director
- Lester J LloydExecutive Officer, Director
- Amount sold
- $1.1M
- Minimum investment
- $12.5K
- First sale
- Apr 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Flow Pharma.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseOffice for Chemical and Biological Defense | Phase IISTTR | 2020 | $537.5K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase ISTTR | 2018 | $136.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Flow Pharma?
- Flow Pharma was founded by Reid Martin Rubsamen, Reid Michael Rubsamen.
- How much funding has Flow Pharma raised?
- Flow Pharma has disclosed $3.8M raised across 4 of its 5 known rounds.
- Where is Flow Pharma headquartered?
- Flow Pharma is headquartered in Warrensville Heights, US.